Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 3, 1999

View Archived Issues

MCH binding receptor identified

Ontogen completes phase I bioavailability study of MDR-modulating compound

Hemosol's Hemolink clinical trial program progresses as planned

PMA for Cygnus's glucose monitor receives expedited review status

Integra LifeSciences's dural graft matrix granted 510(k) clearance by FDA

NeoPath and Bayer Diagnostics collaborate on lung cancer screening test

SB and Finlay Institute of Cuba enter agreement for bacterial meningitis vaccine

Study examines capability of antidementia drug candidate FK-960 to restore rCBF response

Further evidence of the efficacy of JE-2147, an improved HIV protease inhibitor

Neurocrine Biosciences initiates phase II studies for insomnia treatment

PA153, a novel agent for the diagnosis and treatment of pancreatic diseases

Licensing opportunity from NIH: method of inhibiting Hsp90 with novobiocin

Kirin Brewery patents quinoline derivatives with broad potential therapeutic application

Novel MTP inhibitors in early development at Japan Tobacco

DuPont introduces NNRTI in first major European market

Aeolus receives notice of allowance for U.S. patent covering synthetic SOD mimetics

GelTex seeks FDA approval of Cholestagel

Bristol-Myers Squibb describes lobucavir prodrugs with improved oral bioavailability

Zeffix approved in E.U. for chronic HBV

Alcon describes therapeutic potential of ocular antiinflammatory agents

Gilead completes acquisition of NeXstar

Allergan profiles its Ocular Hypotensive Lipids at SOE 1999

Genentech seeks FDA approval for tenecteplase

Travoprost is safe and effective in treating elevated IOP in glaucoma patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...